Read more at CNBC.
FDA approval of Eli Lilly's Alzheimer's drug cements our decision not to take profits
Date: | |
Tag: | FDA |
Sort by
Filter
Date
-
The New York Times - Business
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.FDA -
CBS News - Top stories
FDA approves new treatment to slow progression of early Alzheimer's
The FDA approved a new Alzheimer's treatment called donanemab on Tuesday. It is designed to help patients in the early stages of the disease. CBS News chief medical correspondent Dr. Jon LaPook explains what to know.FDA -
CNBC - Business
We're taking profits in this beer maker and buying more of our newest stock
We will realize a double-digit gain on the sale and pour half of it into our latest addition to the portfolio. -
CNBC - Business
Wall Street firm gets it right with Best Buy call, plus Eli Lilly shares move up
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET. -
MarketWatch - Business
‘He thinks I’m too materialistic’: My husband and I are in our 40s. He takes zero interest in our finances. He doesn’t even know the name of our mortgage company. What can I do?
“I am really worried that if I’m not around, he will not be able to manage the basics of everyday life for himself and our children.” -
CBS News - Top stories
FDA bans ingredient found in some citrus-flavored sodas
Brominated vegetable oil will no longer be allowed in food and beverages in the U.S., 50 years after chemical banned in U.K.FDA -
CBS News - Top stories
Many tattoo ink and permanent makeup products contaminated, FDA finds
The FDA found even some products that claimed to be "sterile" were contaminated. -
The Wall Street Journal - World
Samsung Electronics Expects Surge in Second-Quarter Profit
The South Korean tech giant forecast a surge in second-quarter earnings, suggesting that its flagship semiconductor business sustained a strong recovery. -
The Wall Street Journal - Business
Samsung Electronics Expects Surge in Second-Quarter Profit
The South Korean tech giant forecast a surge in second-quarter earnings, suggesting that its flagship semiconductor business sustained a strong recovery. -
Financial Times - World
Samsung expects profits to surge on demand for AI chips
World’s largest memory chipmaker forecasts 15-fold rise in second-quarter figures
More from CNBC
-
CNBC - Business
Friday's jobs report expected to show slowing payroll gains as concern rises about broader economy
Economists surveyed by Dow Jones expect June to show growth of 200,000, down from the 272,000 reported for May. -
CNBC - Business
Disney heiress, wealthy Democratic donors say they won't finance the party until Joe Biden drops out
President Joe Biden faces a rebellion from wealthy Democratic donors after his debate performance against Donald Trump.Joe Biden -
CNBC - Business
Over $170 billion wiped off cryptocurrencies as market tanks on Mt. Gox bitcoin payout fears
Cryptocurrencies plunged on Friday as investors get anxious about the planned payout of nearly $9 billion to users of collapsed bitcoin exchange Mt. Gox.Crypto -
CNBC - Business
Stocks, property, bonds, the pound: Here’s what a new Labour government means for investing in the UK
As Labour takes power in the U.K., experts weigh in on whether the change in government will impact stocks, bonds, the British pound and property markets. -
CNBC - Business
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition.